Evidence map›Paper›PMID 17160470›Full record

ArticleDigestive diseases and sciences2007

Surgical bypass versus endoscopic stenting for malignant gastroduodenal obstruction: a decision analysis.

Ali Siddiqui, Stuart J Spechler, Sergio Huerta

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 5 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 5 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Enteral Stents for Malignant Gastric Outlet Obstruction: Low Reintervention Rates for Obstruction due to Pancreatic Adenocarcinoma Versus Other Etiologies.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2021
    Article
  8. Article
  9. Current role of palliative interventions in advanced pancreatic cancer.World journal of gastrointestinal surgery · 2018
    Review
  10. Article
  11. Review
  12. Role of stenting in gastrointestinal benign and malignant diseases.World journal of gastrointestinal endoscopy · 2015
    Review
  13. Article
  14. Palliation of jaundice in pancreatic cancer: stent or surgery?Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2013
    Article
  15. Biliary stenting versus surgical bypass for palliation of periampullary malignancy.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2013
    Article
  16. Article
  17. Upper gastrointestinal stent.Clinical endoscopy · 2012
    Article
  18. Laparoscopic pancreatic surgery: what now and what next?Current gastroenterology reports · 2009
    Review
  19. Self-expanding metal stents for duodenal obstruction in advanced pancreatic adenocarcinoma.HPB : the official journal of the International Hepato Pancreato Biliary Association · 2008
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ali SiddiquiDivision of Gastroenterology, VA North Texas Health Care System and University of Texas Southwestern Medical School, Dallas, Texas 75216, USA. Ali.siddiqui@utsouthwestern.edu
Stuart J Spechler
Sergio Huerta
VA North Texas Health Care System · USThe University of Texas Southwestern Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment options for palliating malignant gastroduodenal obstruction include open gastrojejunostomy (OGJ), laparoscopic gastrojejunostomy (LGJ), and endoscopic stenting (ES). The aim of this study was to compare the clinical outcomes and costs among ES, OGJ, and LGJ in patients who present with gastroduodenal obstruction from advanced upper gastrointestinal tract cancer. We designed a model for patients with malignant gastroduodenal obstruction. We analyzed success rates, complication rates and costs of the three treatment modalities: ES, OGJ, and LGJ. Baseline outcomes and costs were based on published reports. Success was defined as no major procedure-related and long-term complications over a 1-month period. Failure of therapy was defined as recurrent symptoms or death due to a procedural complication. Sensitivity analyses and cost-effectiveness analyses for the various strategies were performed. ES resulted in the lowest mortality rate and the lowest cost of the three treatment options analyzed. Mortality in the OGJ group was 2.1 times that in the ES cohort and 1.8 times that in the LGJ cohort. Sensitivity analyses confirmed ES as the dominant strategy. In conclusion, ES is the preferred treatment for palliation of duodenal obstruction due to advanced upper gastrointestinal tract cancer.

Indexed as

Endoscopy, GastrointestinalGastric BypassDecision Support TechniquesDecision TreesDuodenal NeoplasmsGastrointestinal NeoplasmsHumansIntestinal ObstructionPalliative CarePancreatic NeoplasmsStentsStomach Neoplasms

Identifiers

PMID17160470
OpenAlexW2007228341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.